Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000108

President & Immunovant CEO sold 200,000 shares at $36.62 ($7,324,000)

  • President & Immunovant CEO acquired 200,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2026-09-30 Option exercise 10b5-1 +200,000 $3.85 $770,000 1,799,154 D
Venker Eric President & Immunovant CEO 2026-09-30 Sale 10b5-1 −200,000 $36.62 $7,324,000 1,599,154 D
Derivatives
Venker Eric President & Immunovant CEO 2026-09-30 Option exercise · Stock Option (Right to Buy) 10b5-1 −200,000 3,644,834 D
Open-market sales · 200,000 sh · avg $36.62 · $7,324,000
Loading xslF345X06/wk-form4_1790977058.xml…